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Abstract: Usually regarded as less evolved than their more recently diverged vascular sisters, which
currently dominate vegetation landscape, bryophytes seem having nothing to envy to the defensive
arsenal of other plants, since they had acquired a suite of chemical traits that allowed them to
adapt and persist on land. In fact, these closest modern relatives of the ancestors to the earliest
terrestrial plants proved to be marvelous chemists, as they traditionally were a popular remedy
among tribal people all over the world, that exploit their pharmacological properties to cure the most
different diseases. The phytochemistry of bryophytes exhibits a stunning assortment of biologically
active compounds such as lipids, proteins, steroids, organic acids, alcohols, aliphatic and aromatic
compounds, polyphenols, terpenoids, acetogenins and phenylquinones, thus it is not surprising that
substances obtained from various species belonging to such ancestral plants are widely employed
as antitumor, antipyretic, insecticidal and antimicrobial. This review explores in particular the
antifungal potential of the three Bryophyta divisions—mosses (Musci), hornworts (Anthocerotae)
and liverworts (Hepaticae)—to be used as a sources of interesting bioactive constituents for both
pharmaceutical and agricultural areas, providing an updated overview of the latest relevant insights.
Keywords: bryophytes; plants bioactive compounds from early-diverged land; natural antifungals;
plant extracts; mosses; liverworts; hornworts
1. Introduction
Today as in the earliest terrestrial environment, plants are frequently found to man-
age their growth under adverse situations in terms of both abiotic stress and biotic in-
teractions [1]: unfavorable conditions including temperature and UV radiation injuries,
unpredictable water availability, predation and pathogens attack triggered—and still
represent—an evolutionary pressure that challenges the plasticity of plants defense ar-
senal. The exploitation of their chemical weapons for pharmacological purposes dates
back to several decades in a number of fields of application, relying on the observation
that plant metabolites successfully evolved/selected for antagonistic activities against
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microbial pathogens could be employed as the bioactives reservoir, suitable in their native
form or being specifically modified to tailoring their biological effect. So far, turning to
compounds produced by a plant species to fight microorganisms belonging (and adapted)
to its ecological niche has been a winning strategy, as countless are the plant-derived
molecules actually present on the drug market in the form of pharmacophores, biocides
and other antimicrobial agents. However, due to the incessant struggle between organisms
for survival, an increasing occurrence of resistance phenomena is arising, making the
race towards new and effective bioactive compounds more cogent. At the same time, the
documented adverse effects on the environment and human health, the loss of efficacy by
the most commonly commercialized synthetic pesticides, fungicides and insecticides, due
to an indiscriminate use, has increased the need to provide new natural products as an
alternative to hazardous chemicals.
Plants stand as an infinite resource for drug development: it has been estimated that
the 11% of the 252 drugs considered as basic and essential by the WHO are obtained from
flowering plants [2] but a wide amount of phytochemicals provided with antimicrobial
properties was characterized and isolated in representatives of each taxa, from algae to
pteridophytes to higher plants; bryophytes, non-vascular early land plants considered
the link between seed and vascular plants to their algal ancestors, also contribute to
this “phytochemical treasure chest”. Probably, because the necessity of defense against
detrimental microorganisms has characterized the land life since the very beginning,
and the lack of mechanical protection typical of the more equipped vascular plants was
counterbalanced by the biochemical capability in devising active molecular architectures
as a part of the survival strategy.
Bryophytes can be found in every type of habitat, except in the oceans, thus reflecting
the positive species expansion occurred along the evolution. However, bryophytes rarely
prevail in the ecosystems, probably due to the absence of special structures that prevent
water loss (such as thick cuticles, epidermis and functional stomata), the lack of a highly
specialized system for water transport and distribution inside the plant, and a water-
dependent fecundation process.
More than a few biochemical adaptations provided the essential requirements for col-
onization and diversification on land: for example, the ability to establish close interactions
with bacteria and fungi is thought a critical innovation to ensure access to limited and
scattered nutrients, as revealed by the observation that arbuscular mycorrhizal fungi were
found to regularly colonize not only flowering plants but also liverworts and hornworts [3].
Unprovided with mechanical protections typical of cormophytes, shielded by cuticle or
bark against microbial pathogens, Bryophytes survived for more than 350 million years due
to their alternative poikilohydric life strategy, taking advantage of chemical weapons: for
example, the release of phenolic compounds from wetted thalli and phylloids is intended,
and strongly effective, to inhibit the germination of fungal spores that occasionally land on
their surface. Thus, inevitably induced to biosynthesize secondary metabolites functional
to limit biotic stressors, bryophytes are relatively unaffected by microbial diseases although
usually growing in humid habitats, being able to elaborate constitutive or inducible small-
molecule with antimicrobial properties [4]. Therefore, they represent a valuable source
of interesting bioactive compounds: a number of terpenoids (the largest group of sec-
ondary metabolites from bryophytes with more than 1600 structures described) [5] and
aromatic compounds (mainly flavonoids, phenylpropanoids, benzenoids and bibenzyl
derivatives) have been isolated [6–8]. Some of them showed an interesting antimicrobial
potential: several species of liverworts, including Plagiochila, Bazzania and Radula species,
Conocephalum conicum, Dumortiera hirsuta, Marchantia polymorpha, Riccia gangetica, Metzgeria
furcata, Lunularia cruciata and P. vernicosa complex, proved to contain metabolites, such
as marchantin A and lunularin, that displays strong antifungal activity against various
Aspergillus, Penicillium, Fusarium, Candida and Rhizoctonia spp. [9–11]. Others, Trichocolea
mollissima, T. tomentella and T. lanata, possess prenyl-phenyl ethers that are mildly fungi-
cidal [12,13]. Recently, a structural study aimed at understanding the structure of early
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land plants through the comparison of the tube and cell-sheet from Cambrian-to-Devonian
microfossils with experimentally degraded modern liverworts, suggested that the presence
of phenolic compounds was responsible for the protection of lower epidermal tissues
from the soil microbe attack, and provided dimensional stability to the remains of early
marchantioid liverworts similar in some ways to modern Marchantia and Conocephalum [14].
The class of bis(bibenzyl)s, characteristic constituents of liverworts, was proposed to be
the main responsible for their antimicrobial effects; in particular, a significant antifungal
activity was reported against the fluconazole-sensitive and resistant strains of Candida
albicans, where the administration of some bis(bibenzyl)s also facilitated the accumulation
of fluconazole in fungal cells when used in combination [15–18].
The efficacy of organic extracts against different fungal genera was reported for various
mosses, at different extents: interesting inhibitory effects were reported for Syntrichia ruralis,
Grimmia anodon and Pleurochaete squorrosa on S. cerevisiae, while C. albicans, which resulted
in being insensitive to extracts obtained from these species, was strongly affected by the
Tortella tortuosa acetone extract [19]. Aqueous crude extracts of Bryum argenteum and B.
cellulare, cosmopolitan mosses, have been demonstrated to display a containment activity,
at varying degrees, against the two phytopathogenic fungal species Curvularia lunata, the
etiological cause of leaf spot of wheat, and Drechslera maydis, responsible for leaf blight
in Zea mays [20,21]. The inhibitory effect was described not only in terms of hyphae
elongation, but also in terms of spore germination [22], as previously reported for Philonotis
revoluta against the fungus Helminthosporium turcicum, another etiological agent of “corn
leaf blight” [11]. Other phytopathogenic fungi were found to be susceptible to crude
extracts from moss species: Aspergillus niger, Fusarium moniliforme and Rhizoctonia bataticola
development resulted in being highly impaired by the exposure to Thuidium delicatulum
and T. cymbifolium extracts [23], hence highlighting the potential of such Bryopsida as a
source of mycoherbicides to control plant and crop pathogens.
2. The (un)Covered Association
Bryophytes are non-vascular land plants exhibiting a peculiar haplodiplontic life cycle
in which the gametophytic generation is dominant. Bryophytes macrogroup is composed
of three different divisions: the hornworts (Anthocerophyta), liverworts (Marchantiophyta)
and mosses (Bryophyta). The estimated number of bryophyte species is over 24,000 [24],
making this macrogroup the second largest group of terrestrial plants, second only to the
most recently evolved flowering plants. A recent classification described that 250, 7000
and 12,000 bryophyte species belong to the hornworts, liverworts and mosses divisions,
respectively [25].
The long time accepted idea that early land plants were not interested by fungal asso-
ciation has been almost overwhelmed by the copious findings that over the years showed
the contrary. Despite the persistence of such an erroneous misconception—sometimes
attributed to the lack of collaboration between bryologists and mycologists, and to sam-
pling bias for healthy specimens—fungal species forming associations with taxonomically
various mosses have been reported since 1951, when Wilson individuated in some basid-
iomycetous pathogens the real cause of “fairy rings” in Antarctic moss prairies [26] and
continued through the following decades [27–31]. As masterfully reviewed by Davey and
Currah [32], various types of association, both pathogenic and beneficial, actually occur
in the “mosses chamber” of the bryophyte’s world. In terms of their development, these
interactions clearly differ from those occurring between fungi and higher plants, since char-
acteristic targets for predation (such as storage organs and specialized nutrient transport
tissues) and entrance (regulated stomata and lignified, reinforced cell walls around vessels)
are likely missing in bryophytes: thus, the exploitation of degradative enzymes secreted
from the penetration peg seems to represent the most common entry-ticket strategy, for
example in Sphagnum pathogenic fungi [33–35]. The functional relationship with fungal
symbionts, historically conceived as a distinctive trait of land plants, has been reviewed
in 2010 by Pressel and colleagues, which investigated the phylogenetic implications of
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bryophyte–fungal associations unraveling the early evolution of fungal symbioses at the
base of the land plant tree [36]: through the combination of both cytological and sequencing
available data, a more than surprising endophytes diversity was noteworthily found as
consistent with phylogenies. Despite several leafy liverworts families (Jungermanniideae),
around 30% of liverwort species worldwide, are reportedly presenting ascomycete rhi-
zoidal symbionts (while lesser than 100 species with basidiomycetes, glomeromycetes and
mucoromycetes) [37], a demonstration of nutritional mutualisms have been achieved in a
few of early-diverging thalloid and Haplomitriopsida liverworts only and, very recently, in
the leafy Cephalozia bicuspidata colonized by the ascomycete fungus Pezoloma ericae [38]; the
latter in particular was then established as a mycorrhiza-like symbiosis, sanctioning the
Ascomycota as mycorrhizal fungal groups engaging in mutualisms with plants across the
land plant phylogeny.
However, bryophyte-associated fungi must share with vascular plants-associated
cousins the exigency to cope with the host defenses, evolving structural and functional
adaptation to their ecological niche and host habit; questions like: how do bryopathogenic
species overcome the occurrence of prolonged desiccation of their host? or what is the
actual mechanism of host cells disruption exerted by these pathogens, when, in most cases,
the absence of penetrating structures has been noticed? are still to be fully addressed.
On the other hand, in a few species of mosses, some pathogen-response tools—such as
resistance homologous genes and an oxidative burst triggered by hydrogen peroxidases
activity during the fungal spread—have been found in common with higher plants [39,40]
and, recently, similar but more detailed findings at both the transcriptional and proteomic
level have been reported for the liverwort Marchantia polymorpha: Carella and coauthors, in
fact, showed in 2019 that in M. polymorpha the infection by the phytopathogenic oomycete
Phytophthora palmivora activates a phenylpropanoid metabolic pathway, displaying same
deterrence strategy that, million years later, will evolve in the phenyl-propanoids-associated
biochemical defenses so well characterized in Angiosperms [41]. Hence, it could be easily
speculated that these compounds (namely polyphenols, flavonoids and anthocyanins),
providing an ancestral layer of biochemical defenses in mitigating pathogen infection in
liverworts, played a critical role for the terrestrialization of plants.
3. Phytochemistry of Bryophyte’s Antifungal Metabolites
Bryophytes evolved a vast chemical arsenal with more than 3000 different metabo-
lites [42–44]; in particular, the most representative class with 2200 different molecules are
terpenoids, followed by phenolic compounds (several hundred) and other molecules, such
as saccharides, lipids, nitrogen- and sulfur-containing compounds [25]. During decades, as
dedicated investigations have been carried out, the enumeration of antifungal compounds
detected in bryophytes is continuously increasing. Biological activities were both reported
from crude plant extracts in various solvents and purified compounds; in the first case, as
diffusely described for higher plants, the effectiveness of a bryophyte extract in exerting
the fungicide/fungistatic effect strongly depends on its balsamic period, and on seasonal,
territorial (latitude and altitude and substrate composition) and climate variations that
specifically influence the phytochemical composition of the plant tissues and, in turn,
determine their pharmacological potential [45].
Aside from abiotic factors, particular, even poorly investigated, biotic interactions
have been revealed to be connected with the antifungal potential of bryophytes, as in the
case of the association between bacteria and Tortula ruralis, Aulacomnium palustre and Sphag-
num rubellum, typical moss species belonging to nutrient-poor plant communities. Through
the analysis of the antagonistic activity of bacterial isolates against the phytopathogenic
fungus Verticillium dahliae, a high percentage (99%) of moss-associated bacteria was found
to produce antifungal compounds [46], suggesting genus Sphagnum as a promising source
of antagonistic molecules against human fungal pathogens [47]. Although their acknowl-
edged antimicrobial potential, the bryophytes have not been fully characterized chemically
and pharmaceutically, also due to the difficulty of classification and collection of a sig-
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nificant number of species; however, to date, the various attempts to fill this gap have
successfully determined notable progress, shedding light on a plethora of metabolites with
acknowledged, or potentially even not assessed yet, antifungal properties. As follows, the
major secondary metabolites of these early-diverged land plants, grouped depending on
their chemical features, are reported and discussed.
3.1. Terpenes
Plant-derived bioactives are mostly labeled as an antioxidant: these phytochemicals
are redox-active molecules, and, dynamically involved in maintaining the redox balance
in the cell, have been frequently proven to exert an inhibitory effect on the fungal growth
and development. Terpenoids, flavonoids and bibenzyls are the most widely described
antioxidants found in the secondary metabolism of bryophytes [42], showing a high level
of variability, in terms of relative abundance, within different species; for example, amongst
liverworts, the chemical profile of Radula species is very distinctive with respect to other
species: in fact, if they mainly elaborate bibenzyls (including bibenzyl cannabinoids and
prenyl bibenzyl derivatives) and bis-bibenzyls, the distribution of terpenoids is generally
almost limited, with some exceptions for Portuguese species that appear to be a rich source
of sesquiterpenoids [48]. On the other hand, 264 of 679 liverwort species so far examined
proved to contain α-tocopherol, which antioxidative properties are assumed to be pivotal
for the constituents of oil bodies of liverworts and supposedly the cause of its activity
against plant pathogenic fungi [49].
Terpenes and terpenoids constitute a group of natural and biochemically active
metabolites that have been found in all living organisms [50]. For example, steroids are
essentials components of cell membranes in eukaryotic cells and carotenoids are pivotal in
photosynthetic organisms. Therefore, it has been speculated that the terpene and terpenoid
biosynthetic pathway might be very ancient. Bryophytes are also capable to synthesize
a vast variety of terpenes and terpenoids and many of these metabolites resemble those
observed in flowering plants, while others are peculiar of some bryophytes [42,51]. In par-
ticular, it has been reported that liverworts synthesize around 1600 terpenoids [5] and one
reason of this high structure variety might lie in the high presence of oil bodies—discussed
above—a distinctive cellular compartment of liverworts [52]. These intracellular organelles
are surrounded by a single membrane layer and include proteins, lipophilic materials, some
phenolic compounds (marchantins) and terpenoids [53]. Neither mosses nor hornworts
possess these compartments, but they have the ability to produce different types of ter-
penoids as well. From a structural point of view, terpenes are simple hydrocarbons, while
terpenoids (also called isoprenoids) are terpenes in which the structure has undergone
rearrangements and modifications with the addiction of one or more oxygen residues.
However, the terms “terpene” and “terpenoid” are often used interchangeably [54]. The
classification of terpenoids is based on the number of carbon atoms included in the struc-
ture and in bryophytes the most common and characteristics are monoterpenoids (C10),
sesquiterpenoids (C15), diterpenoids (C20) and triterpenoids (C30).
Monoterpenoids are peculiar metabolites that contribute to the characteristic fra-
grances of the plant material when crushed. In particular, sabinene, α-pinene, limonene
and the acetate derivatives of borneol, nerol, geraniol and myrtenol are accumulated in
liverwort [55], whereas the most mosses synthetize ß-citrocitral, α- and ß-pinene, limonene,
camphene and bornyl acetate [42]. For some of them, an antifungal activity is well docu-
mented [56]. The few data reported for the hornworts suggest that limonene is the most
abundant monoterpenoid produced in Anthoceros caucasicus, followed by α- and ß-pinene,
myrcene and terpinolene [57].
Sesquiterpenoids includes three isoprene units and display a variety of forms, spacing
from linear to mono-, bi- and tricyclic structures. Sesquiterpenoids represent the widest
group of terpenoids produced by bryophytes. As well explained in a recent review [44],
liverwort produces around 900 types of sesquiterpenoids deriving from 60 different skele-
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tal groups. Eudesmane and aromadendrene structures are the two most representative
backbones, followed by cuparane, pinguisane and barbatane [42] (Figure 1).
Figure 1. Terpenoid biosynthetic pathway in bryophytes. Red, orange and cyan arrows indicate the metabolic fluxes
observed in mosses, liverworts and hornworts, as suggested in various reports (see references in the main text). Arrow
thickness represents the amount of carbon streams (resources) committed for the production of specific metabolites in a
specific bryophyte division. The question marks next to the faint arrows state that no information is available about the
production of squalene and triterpenoid in hornworts.
A peculiarity of liverwort sesquiterpenoids is that many are enantiomers of those
found in seed plants [5], with few exceptions regarding germacrane- and guaiane-type
sesquiterpenoids [43]. For example, it was seen that both Conocephalum conicum (liverwort)
and Leptospermum scoparium (angiosperm) are able to produce cadina-3,5-diene, but the
former synthesizes the (+)-enantiomer, whereas the latter the (-)-enantiomer [58]. More-
over, frullanolide and β-caryophyllene can be found in both enantiomeric forms in the
liverworts Frullania tamarisci and Pellia epiphylla, respectively [59–61]. Another interesting
feature of some liverwort sesquiterpenoids lies in the occurrence of these metabolites in
nature: in fact, while some sesquiterpenoids such as the pinguisanes were only found in
liverworts [42], others, despite appearing also in other organisms, are almost rare (such as
1,10-seco- and 2,3-seco-aromadendranes and africane-type sesquiterpenoids [6,42,55,62,63]).
Finally, some sesquiterpenoids are liverwort species-specific [5]. In mosses, the number
of sequiterpenoids was estimated around 100, a value substantially lower than that en-
countered in liverworts [42]. A possible explanation, beside the presence of oil bodies in
liverworts, is that liverworts have been much more studied than mosses, resulting in a
deeper knowledge of the chemical composition. Sesquiterpenoids are also produced in
hornworts, as reported by Sonwa and Konig (2003) [57], but the available information on
this division is still almost limited. Among the sesquiterpenoids, Neves and coworkers
(1999) investigated the ability of Targionia lorbeeriana (a liverwort) extracts against two
fungal pathogens: Cladosporium cucumerinum and Candida albicans [64] The former infects
many species belonging to the Cucurbitaceae family, whereas the latter is a well-known
animal pathogen. In that report, three guaianolide-type sesquiterpene lactones and two
germacrane-type sesquiterpene lactones were extracted, isolated and tested, revealing that
the main sesquiterpene lactone constituent of T. lobeeriana, the dehydrocostus lactone, was
particularly effective against C. cucumerinum. Moreover, the acetyltrifloculoside lactone and
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11-αH-dihydrodehydrocostus lactone exerted antifungal activity towards C. cucumerinum
as well, even in a less extent. On the other hand, among the five tested compounds, only the
8,15-acetylsalonitenolide (a germacranolide) showed activity against C. albicans. The fifth
compounds, i.e., the 8-acetylsalonitenolide (a germacranolide), did not show any biological
activity in the bioassays. In the report of Scher et al. (2004), different compounds extracted
from Bazzania trilobata (a liverwort) were tested against different fungal pathogens, such as
Botrytis cinerea, Cladosporium cucumerinum, Phythophthora infestans, Pyricularia oryzae and
Septoria tritici [65]. More in detail, six sesquiterpenes, such as 5- and 7-hydroxycalamenene,
drimenol, drimenal, viridiflorol and gymnomitrol, showed different growth inhibitor ac-
tivities. 5-hydroxycalamenenes was particularly effective in the inhibition of P. oryzae,
whereas the 7-hydroxycalamenenes towards all the pathogens. Furthermore, this last was
also tested in vivo in a glasshouse environment and it showed a significant reduction in
the infection of grape vine leaves caused by Plasmopara viticola when used at 250 ppm.
Drimenol was active against C. cucumerinum, whereas the aldehydic form, i.e., drimenal,
showed a strong inhibiting activity against S. tritici and P. infestans. Viridiflorol showed
weak activity against C. cucumerinum and P. oryzae. Gymnomitrol exerted strong activity
against P. infestans and moderate against C. cucumerinum, P. oryzae and S. tritici.
Diterpenoids are specialized metabolites deriving from the condensation of four
isoprenyl units. They are the second largest group of terpenoids accumulated in liverworts.
More in detail, about 500 compounds have been reported in liverworts so far, including
acyclic, di-, tri-, tetra- and pentacyclic diterpenes. From a structural point of view, the
most part of diterpenoids are based on clerodane, kaurane and labdane skeletons [5,42]
(Figure 1). Interestingly, succulatane, infuscane, abeo-labdane, spiroclerodane, 5,10-seco-
clerodane or 9,10-seco-clerodane backbones were found to be liverwort-specific [42]. In
mosses, the number of identified diterpenoids is lower and non-exclusive of this division.
For example, the momilactone diterpenoids extracted from Hypnum plumaeforme (moss)
were also found in rice [66]. As for sesquiterpenoids, diterpenoids were also found in
hornworts [57]. Among the diterpenoids, momilactones A, B and F, and acrenol were
extracted from the moss Hypnum plumaeforme Wilson and they strongly inhibited the
growth of the fungal pathogens P. oryzae, Colletotrichum acutatum and Ustilago maydis [67].
More in detail, the growth of the rice pathogen P. oryzae was inhibited by momilactones A
and B, with the latter showing a greater efficacy against spore germination and germ tube
growth of the fungus [68]. Momilactone A and B activities were also investigated on other
fungal pathogens, giving encouraging results in the inhibition of B. cinerea, Fusarium solani
and Colletrotrichum gloeosporioides [69].
Triterpenoids derive from the condensation of six isoprene units. In liverworts,
the most common triterpenoids are hopanoids, including diploptene, diplopterol and
α-zeorin [5,42]. In comparison to mono-, sesqui- and diterpenoids, mosses are richer in
triterpenes, including ursane, fernane, friedelane, hopane, lupane, taraxane, cycloartane,
obtusifolane, dammarane, polypodane and serratane [5,42]. No data are available about
triterpenoids in hornworts so far.
3.2. Phenolic Compounds
Bryophytes are considered a phylogenetic divergent group from the most evolved vas-
cular plants. These are organisms able to synthesize lignin, a polymer that results from the
polymerization of monolignols and it is one of the final products of the phenylpropanoid
pathway. Lignin and lignans, which share monolignols as common precursors, are both
involved in the plant defense against pathogens, often resulting fungal elicitors [70]. In
bryophytes, the presence of candidate orthologous genes encoding for enzymes involved
in the production of the monolignols p-coumaryl alcohol and coniferyl alcohol (that has
been reported to act as a fungicide against Ceratocystic spp. pathogens [71] and is effec-
tive in inhibiting the growth of Verticillium longisporum) in Physcomitrella patens has been
reported [72–74] but true lignin has never been detected, meaning that at least part of the
biosynthetic machinery involved in lignin formation is present in these plants [75–77].
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Monolignols are also precursors of lignans that were found in several bryophytes and
some of them are currently used as chemical markers in chemosystematics. For example,
megacerotonic and anthocerotonic acids are peculiar lignans of hornworts [42], and show
a relationship to the antifungal defense compound rosmarinic acid [78]. A simplified
scheme representing the phenylpropanoid pathway and part of its branches in bryophytes
is depicted in Figure 2.
Figure 2. Simplified phenylpropanoid pathway and some of its putative branches in bryophytes. Red, orange and cyan
arrows indicate the metabolic fluxes observed in mosses, liverworts and hornworts respectively, as suggested in various
reports (see references in the main text). Dashed arrows indicate multiple reaction steps between the precursor and product.
The phenylpropanoid pathway is the initial way for the production of other metabo-
lites in flowering plants, such as benzoic acid, phenylpropanoid esters, hydroxycinnamic
acids (including differently esterified and/or etherified acids), acylated polyamines, phenyl-
propenes, flavan-3-ols, aurones, stilbenes, isoflavonoids, flavonoids and coumarins [79].
In bryophytes, the production of different phenolic compounds belonging to some of the
previously mentioned classes has been reported [80,81]. For example, hydroxycinnamic
acid derivatives, such as methyl p-coumaric acid and caffeic acid methyl ester, have been
detected in hornworts [82] and rosmarinic acid (Figure 2) and its glucoside [83]. Again, 4-O-
caffeoylquinic, 5-O-caffeoylquinic and caffeic acids were detected in the two mosses Brachythe-
ciastrum velutinum and Kindbergia praelonga [77]. Besides these compounds, bryophytes are
known to produce derivatives of benzoic acids [42,84], stilbenes [85], coumarins [86,87] and
different flavonoids, including flavones (apigenin and luteolin derivatives for example) [77];
flavonols (quercetin) [77], isoflavones [88], dihydroflavonols [89] and aurones [90,91]. In-
terestingly, genes involved in phenylpropanoid-polyamine biosynthesis are not found in
bryophytes [92]. Phenylpropanoids have been found to be important for the response
of Arabidopsis thaliana against some fungal pathogens [93]; at the same time, the phenyl-
propanoid biosynthetic pathway has been shown to be activated after the assault of different
pathogens in mosses. For example, the two fungal pathogens B. cinerea and Colletotrichum
gloeosporioides triggers the activation of genes involved in phenylpropanoid production
in P. patens [94–96], thus suggesting a role of these substances in plant protection. More-
over, five aromatic esters isolated from Balantiopsis cancellata, including 2-phenylethyl
(Z)-cinnamate and 2-phenylethyl (E)-cinnamate, showed antifungal activity towards Cla-
dospirum herbarum [97]. Finally, isoprenyl benzoates found in the liverwort Trichocolea
tomentella, such as tomentellin and demethoxytomentellin, and trichocolein, isolated from
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Trichocolea lanata, displayed antifungal activity against C. albicans and Trichophyton menta-
grophytes [12].
In comparison with flowering plants, many phenolic compounds are found in a multi-
meric form in bryophytes. Bibenzyls, bisbibenzyls and bisbibenzyl dimers are peculiars
of liverworts [98]. Marchantins, riccardins, plagiochins, bazzanins and lunularic acid are
only some examples of this molecule class [42,99]. Marchantin A (Figure 2) was the first
characterized member of cyclic bis(bibenzyls) molecules found in the liverwort Marchantia
polymorpha [6,100] and its synthesis was proposed to occur through the condensation of
monomeric bibenzyl precursors, such as lunularic acid (Figure 2) and lunularine [60].
Moreover, other compounds seem to be involved in marchantin A production, such as L-
phenylalanine, acetate, malonate, cinnamic acid, p-coumaric acid and dihydro-p-coumaric
acid [101]. Marchantin A from M. polimorfa and marchantin C, neomarchantins A and B
from Schistochila glaucescens were reported to be active against the dermatophytic fungus Tri-
chophyton mentagrophytes [102,103]. Riccardin A, isolated from Riccardia multifida [104,105],
and plagiochin A (a macrocyclic bisbenzyls, Figure 3), characterized from Plagiochila scio-
phila [106], are other macrocyclic bisbibenzyls, and some related compounds, such as
riccardin D, riccardin B, asterellin A, asterellin B, 11-demethylmarchantin I, dihydrop-
tychantol, marchantin H, marchantin M and marchantin P showed antifungal activity
against C. albicans [107,108]. Plagiochin E from M. polimorfa was also found to inhibit the
growth of C. albicans as well, by negatively affecting the cell wall chitin synthesis [109].
The linear bisbibenzyl perrottetins E was detected in Radula perrottetii [105], while the
bisbibenzyl dimer pusilatin A was isolated from Blasia pusilla [110]. Lunularic acid was
isolated from Lunularia cruciata: it promotes dormancy and inhibits growth in liverworts,
and, interestingly, it displays a weak antifungal activity [111]. Among the bibenzyls,
it is worth to recall that Radula species accumulate rare bibenzyl cannabinoids [42,63]
(Figure 3). Regarding the antifungal activity, the three polychlorinated bibenzyls 2,6-
dichloro-3-hydroxy-4′-methoxybibenzyl, 2,6,3′-trichloro-3-hydroxy-4′-methoxybibenzyl
and 2,4,6,3′-tetrachloro -3,4-dimethoxybibenzyl extracted from some Riccardia sp. have
been shown to exert an effect against the growth of Cladosprium herbarum [97]. Moreover,
three bisbibenzyls, such as bazzanin B, isoplagiochin D and bazzanin S, isolated from Baz-
zania trilobata have been shown to moderate inhibit the growth of B. cinerea, Cladosporium
cucumerinum, P. infestans and S. tritici, whereas the strongest activity was observed for M.
oryzae [65]. Finally, marchantin A isolated from Marchantia sp. showed antifungal activities
against several fungi, including Alternaria kikuchiana and Rhyzoctonia solani [9].
Figure 3. Examples of the biflavonoid Hypnogenol B1, the bibenzyl cannabinoid Perrottetinene and
the Sphagnorubin A.
Biflavonoids and triflavonoids are typical of mosses [42,99,112], whereas liverworts
mainly produce monoflavonoids, which are usually C-glycosides and O-glycosides. For ex-
ample, the two mosses Hypnum cupressiforme and Bartramia stricta produce the biflavonoids
hypnogenol B1 (Figure 3) and 5′,3′′′-dihydroxyamentoflavone, respectively, whereas the
liverwort Lunularia cruciata is able to synthesize luteolin-7-O-glucoside and quercetin [77].
Finally, the synthesis of the triflavonoid aulacomniumtriluteolin has been reported in Aula-
comium paustre. It has been suggested that biflavonoids might negatively affect the growth
of fungal pathogens since extracts of the moss Hypnum cupressiforme showed antifungal
activity and these extracts were rich of polycyclic aromatic hydrocarbons, hypnogenols,
biflavonoids and hydroxyflavonoids [113–115].
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The ability to generate multimeric forms of flavonoids is considered as a higher evolved
character in mosses. In particular, it has been reported that the moss Takakia lepidozioides, which
is considered one of the most primitive moss, synthesizes only monoflavonoids, including
flavone O-glucuronides, flavone C-glycosides and flavonol O-glycosides [116], whereas
more evolved mosses mainly produce bi- and tri-flavonoids. Interestingly, hornworts
do not synthesize flavonoids [117–119]. It was hence suggested the hypothesis that the
flavonoid biosynthetic pathway might be absent in hornworts due to an earlier phyloge-
netic divergence from other land plants, in which this feature developed later. However,
it cannot be excluded that flavonoid genes might have been lost during the evolution in
hornwort. Further studies are needed to clarify this aspect. Bryophytes also produce pig-
mented substances: aurones have been isolated from both mosses and liverworts [91,120],
auronidins (Figure 2) from Marchantia [120] and sphagnorubins (Figure 2) from Sphagnum
species [121]. Auronidins were initially associated to anthocyanidins, due to the similar
pigmentation provided; for example Riccionidin A (Figure 2), an auronidin associated to
the cell wall of the liverwort Ricciocarpos natans [122], was found to be responsible for its
red pigmentation. However, a substantial difference in the chemical nature of auronidins
and anthocyanidins has been recently reported: in fact, although the initial steps of the
flavonoid pathway are in common, the final part of the biosynthetic pathway might be
different; additionally, auronidins possess fluorescence properties stronger than antho-
cyanidins [120]. Unfortunately, at the best of our knowledge, no information is available in
literature regarding the antifungal property of these pigmented compounds.
3.3. Other Compounds
Bryophytes produce and accumulate a vast array of other molecules exerting biolog-
ical effects, including saccharides, lipids, vitamins and nitrogen- and sulfur-containing
compounds. Some examples are reported in Figure 4. Beside the traditional saccharides,
for example sucrose, which can be found in both flowering plants and bryophytes, tri-,
oligo- and polysaccharides, such as the rare fructooligosaccharide 1-ketose extracted from
the moss Rhodobryum ontariense and the liverwort Porella platyphylla [123,124], are unique
for bryophytes. Lipids found in bryophytes include (i) membrane lipids, such as sterols
(in particular, in higher evolved mosses have been found stigmasterol, campesterol and
sitosterol), fatty acids and glycerol-, phosphor- and sphingo-lipids; (ii) storage lipids, such
as triacylglycerols and sterol esters; (iii) surface lipids involved in the formation of part of
the cuticle, such as cutin and waxes and (iv) signaling lipids, including phosphoinositides
and oxylipins [125]. Interestingly, mosses are known to produce long unsaturated fatty
acids, such as the eicosanentaenoic and arachidonic acids [24]. Vitamin E (α-tocopherol)
and K were found in liverworts and it was demonstrated that, among 700 liverworts,
almost all contained α-tocopherol and squalene [126]. It should be noted that, in seeds
oil, tocopherols have been indicated as the major antifungal principles, due to their an-
tioxidant properties [49]. Nitrogen- and sulfur-containing compounds are almost rare in
bryophytes. In liverworts, for example, the nitrogen- and sulfur-containing compounds
coriandrins (isothiocyanates, Figure 4) are present in Corsinia coriandrina [127], and the
nitrogen-containing alkaloid plagiochianin B (Figure 4) from Plagiochila duthiana [128]
and two prenylated indole derivatives from Riccardia species [129]. In mosses, another
nitrogen-containing alkaloid (harmol), active against both the phytopathogenic fungi Peni-
cillium digitatum and Botrytis cinerea [130], was reported from Fontinalis squamosa [131].
In hornworts, Anthoceros agrestis was found to contain nitrogen-containing molecules
such as glutamic acid amide derivatives of hydroxybenzoic-, protocatechuic-, vanillic,
isoferulic and coumarylic acids [132], some of them with a well characterized inhibitory
activity against fungal pathogens [133–135]. N-(4-hydroxybenzoyl)-glutamic acid, N-(3,4
dihydroxybenzoyl)-glutamic acid and N-(4-hydroxy-3-methoxy-benzoyl)-glutamic acid
structures are showed in Figure 4.
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Figure 4. Some example of other molecules produced in bryophytes and three having antifungal effects, such as the N-(4-
hydroxybenzoyl)-glutamic acid, N-(3,4 dihydroxybenzoyl)-glutamic acid and N-(4-hydroxy-3-methoxy-benzoyl)-glutamic acid.
4. Mining with the Omic-Technologies: New Generation Approaches That
Contributed—and Still Do—to the Individuation of Antifungal Bryo-Actives
The exploration of new molecular targets for antifungal compounds has generated
considerable research, especially using modern omics methods (genomics, genome-wide
collections of mutants and proteomics) and bioinformatic approaches. Recently, micro- and
nanoscale strategies have been introduced in the drug discovery focused on antifungals.
Microfluidic platforms have been developed, since they possess several advantages if
compared to traditional multiwell-plate screening: among them, the low reagents con-
sumption, the possibility to simultaneously and independently manipulate a huge num-
ber of samples, and the ease of integrating various analytical standard operations and
large-scale integration, are the most attractive [136]. Despite a low morphological com-
plexity, bryophytes generally display a high degree of chemical diversification [42,63,137],
which reflects specific diversification at the genetic level. In this section, we show how,
at a molecular level, the in depth analysis offered by the meta-omics approaches (which
mainly include metagenomic, transcriptomic, proteomic and metabolomic studies) re-
sulted in being highly informative in the case of bryophytes and it is already acknowl-
edged for higher plants, with particular regard to the functional diversity of antifungal
bioactive compounds.
4.1. Genomics and Transcriptomics
The functional genomics approaches, aided by targeted-metabolite and transcriptome
profiling, represented a highly effective way to deciphering novel gene functions involved
in specialized metabolic pathways in medicinal plants, enabling not only drug discovery,
but also drug development and large-scale production of phytomedicinals. Although
several bioactives (such as antifungal and antimicrobial compounds, including enzymes)
are reported from bryophytes, the characterization of most of them at a genetic level has not
been achieved yet; in fact, despite the relatively low cost of sequencing, de novo assembly
of whole genomes without prior sequence information is still costly, and requires intensive
computational resources [138].
Even after 15 years of next generation sequencing (NGS) technology availability,
genome sequence of only seven bryophyte have been reported to date: (i) the nuclear
genome of the desiccation-tolerant moss Physcomitrella patens (480 Mbp; 35,938 protein-
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coding genes), which was firstly sequenced in 2008 and then reannotated in 2013. The
data provide an excellent resource for functional and comparative genomics, since a
large number of knockout lines are available at the International Moss Stock Center
(http://www.mossstock-center.org/) [139,140]; (ii) the genome of the liverwort Marchantia
polymorpha (225.8 Mb; 19,138 protein-coding genes), released in 2017 [141]; (iii) the genome
of the dioicous moss Ceratodon purpureus (362.5 Mb; 19,138 protein-coding genes; Ceratodon
purpureus GG1 v1.1 DOE-JGI; http://phytozome.jgi.doe.gov/) [142] and (iv) the genome
of the hornwort Anthoceros angustus (148 Mb, 14,629 protein-coding genes) [143]. More
recently, annotated genomes of (v) M. paleacea (238.61 Mb), (vi) M. polymorpha ssp. poly-
morpha (222.7 Mb) and (vii) M. polymorpha ssp. montivagans (225.7 Mb) have been also
reported Radhakrishnan et al. (2020) [144]. Currently, only four complete chloroplast
genomes are available, sequenced in Physcomitrella patens (122,890 bp) [145], Tortula ruralis
(122,530 bp) [146], Tetraphis pellucida (127,489 bp) [147] and Tetraplodon fuegianus
(124,374 bp) [148].
Acquiring knowledge on the bryophyte genomes is critical not only to clarify their
evolutionary and phylogenetic relationship with vascular plants, but also to identify
genes potentially involved in the biosynthesis of antifungal (when not fungal-interaction
modulating) substances. For example the two genomic regions Fungal Region 1 (FR1) and
Fungal Region 2 (FR2), identified in the nuclear genome of Physcomitrium patens, proved to
contain mostly fungi-specific genes and mobile genetic elements [149]: based on sequence
similarity, both regions were found to contain genes that could be roughly classified into
three families encoding, respectively, a heterokaryon incompatibility protein (HET) domain
that reportedly functions in the self/non-self recognition system of filamentous fungi), a
HopQ1-like protein (HLP) that may act as a virulence factor in bacteria (Pp3c13_910), and
a conserved hypothetical protein with unknown function but identified as a conserved
fungal gene (CF). Strikingly, all these gene families (CF, HLP and HET domain-containing
genes) appear to be functionally related to fungal interactions with other organisms, either
different fungi or host plants. The authors speculated that, albeit some genes could been
coopted by mosses for activities not directly related to interactions with fungi, some other
fungi-derived genes might have been recruited to regulate, or counteract, the activities of
same fungi against the plant, in addition to their roles in other processes.
To the so-called “resurrection plants” (a group of land plants tolerating extreme de-
hydration of their vegetative tissues and still quickly regain normal physiological and
metabolic functions after rehydration) commonly are ascribed various bryophytes species,
while rarely Pteridophytes and Angiosperms are found and no gymnosperms are repre-
sented [150]. Adaptation to extreme dehydration supposedly relies on the development of
unique molecular mechanisms to protect these plants against desiccation-induced dam-
age, including the expression of stress-protective genes and high abundance of protective
metabolites [151]. Nevertheless, sequencing the genomes of bryophytes belonging to the
could not be always achieved without complications, due to the large size, the lack of
detailed genetic maps and the presence of repetitive sequences, that make straightforward
annotations challenging [152]. Although the primary interest in resurrection species has
been fuelled by their ability to withstand desiccation and, in turn, to their potential as
a source for targeted gene discovery [153–156], the unique metabolites that frequently
characterize such species have recently attracted much more attention with respect to
potential uses in biotechnology and medicine; for example, Amentoflavone isolated from
Selaginella tamariscina has strong anticancer/proapoptotic, antibacterial and antifungal
activities [157–159]. If compared with whole genome sequencing, de novo transcriptome
analysis has made it possible to unravel the genetic architecture of those organisms for
which a reference genome was not available yet, at a low cost and computationally less
intensive. The analysis of randomly selected cDNA clones or expressed sequence tags
(ESTs), given this name because they represent only genes expressed at a particular time
or under a particular circumstance, has been an important technique for the discovery of
new genes [160]. Nevertheless, very few transcriptome data addressed to identification of
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antifungal compounds have been reported in bryophyte, while most of the works were
aimed at identifying abiotic responses. This powerful technique was applied to investigate,
at the transcriptomic level, the response of P. patens treated with abscisic acid [161] or
cytokinin [162], and the response of T. ruralis to desiccation [163]. The published moss
EST databases are relatively small, as 253 ESTs derived from P. patens and 152 ESTs from
T. ruralis with the majority of the ESTs (52% and 71%, respectively) showed no significant
similarity to previously characterized genes. More recently, “The 1000 plants”, an interna-
tional multidisciplinary consortium generating large-scale gene sequencing data for over
1000 species of plants, reported 55 bryophyte transcriptomes, from 41 sample of mosses
and 14 samples of hornworts (oneKP, or 1KP; https://db.cngb.org/onekp/) [164,165].
Among secondary metabolites involved in abiotic stress, terpenoids have long time
been recognized to play an important role in bryophyte, and in vascular plants, environ-
mental interactions [5,136]: in fact, over the last four decades, more than 1600 compounds
belonging to the terpenoids family have been reported from this plant lineage [6,42,60], a
number of them demonstrating the ability to possess antioxidant, antimicrobial and cyto-
toxic activities that suggest a potential for pharmaceutical purposes—mainly addressed to
emerging drug resistance occurrences. In this scenario, Singh et al. [166] analyzed, in 2015,
the transcriptome of the thalloid liverwort Dumortiera hirsute, highlighting a total of 33,
662 unigenes; afterwards searched for various pathways involved in the D. hirsuta metabolism,
the transcriptome revealed 95 significant pathways. In particular, amongst the 721 unigenes
constituting metabolic pathways, 309 unigenes were relevant to secondary metabolites
biosynthesis. A strong representation of genes for terpenoid (29 genes), abscisic acid
(28 genes) and flavonoids biosynthesis (10 genes) were observed. These were supposed
to be the major components of both biotic and abiotic stress tolerance, and thought to be
involved in cell signaling [167].
A transcriptomic approach was also used to screen RNA samples from M. polymor-
pha thalli, by using Illumina HiseqTM 2000 instrument. Marchantin A, the first charac-
terized macrocyclic bis(bibenzyls) found in this liverwort, showed interesting antifun-
gal activities [42,60,137]. Moreover, Friederich et al., (1999) [101] reported the phenyl-
propane/polymalonate pathway in the biosynthesis of the marchantins in M. polymorpha.
Thus, to clear this pathway, transcriptome sequencing and digital gene expression analyses
of M. polymorpha were carried out by using the Illumina RNA-seq system [168]. Transcrip-
tome de novo assembly for the identification of novel genes responsible for the biosynthesis
of secondary metabolites was also performed on Radula marginata in the absence of a refer-
ence genome [138]. Due to this investigation, a structural analog of tetrahydrocannabinol
(19-THC)—a psychopharmacological compound belonging to the class of terpenophenolics
typical of Cannabis sativa L.—was found, and, even if cannabinoids have been widely
characterized in different plant species, this was the first report of similar compounds in
an early plant. Cannabinoids have a wide-ranging role in numerous clinical applications,
which exploit their antimicrobial and antifungal capabilities (in addition to a biological
effect on insects and mollusks, piscicidal properties, antileishmanial and antitrypanosomal
and cytotoxicity and anti-inflammatory activities [169]. Thus, the individuation of such
a metabolite in R. marginata results in being of great importance, since, because of the
relatively simple architecture and the diversity of its natural habitats, this plant could be
suggested as an alternative source of earning.
Even though research about the regulation of the plant–pathogen relationship in
early-diverging land plants has become more popular in different areas, the underlying
mechanisms and interactions between many transcription factors and their associated
stress-responsive genes are not fully understood yet, especially at the ancestral state. Re-
cently, Carella et al., (2019) [41] defined the transcriptional and proteomic response of
the early-divergent M. polymorpha to infection with the pathogenic oomycete Phytophthora
palmivora. To gain further insight into the classes of M. polymorpha loci responding to P.
palmivora infection, the analysis was focused on RNA-seq and proteomics datasets on the
annotations, and phylogenetic analyses of conserved land plant gene families, described
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by Bowman et al. (2017) [141]. In this case, authors revealed different responding sets of
Marchantia gene families, including those associated with transcriptional regulation, the
cell wall and cuticle, hormone biology, phenylpropanoid (flavonoid) biosynthesis, lipid per-
oxidation, terpene synthesis, vesicular trafficking, transporters and membrane H+-ATPases,
kinases and receptors already described in these plants [97,170]. Taken together, the results
demonstrated that the Marchantia response to oomycete infection displayed evolutionarily
conserved features indicative of an ancestral deterrence strategy against fungal pathogens
and based on phenylpropanoid-mediated biochemical defenses. A comparative RNA-seq
analysis conducted on the angiosperm Nicotiana benthamiana interested by Phytophthora
infection, let to the discovery of groups of pathogen-responsive genes orthologous in
Marchantia and Nicotiana, which included genes encoding for enzymes associated with
phenylpropanoid and flavonoid biosynthesis such as phenylalanine ammonia lyase (PAL),
chalcone synthase (CHSs), chalcone isomerase (CHI-like) and cinnamate 4-hydroxylase
(C4Hs), resulted in being upregulated in this condition. More importantly, the same
genes found in oomycete-colonized N. benthamiana were shown to be similarly induced
in moss treated with microbial elicitors [171,172] or infected with Pythium irregular [173].
Additionally, these data also suggested a role for a phylogenetically basal R2R3-MYB
transcription factor, MpMyb14, in mediating the flavonoid-associated biochemical defenses
during pathogen infection in M. polymorpha thalli. In particular Mpmyb14 mutants, which
are defective in activating phenylpropanoid biosynthesis gene expression, exhibited an
enhanced susceptibility to P. palmivora infection, whereas the ectopic overaccumulation
of MpMyb14-regulated pigments dramatically suppressed pathogen growth in planta,
suggesting a protective role for these compounds during biotic stresses.
4.2. Proteomics
In recent years, advances in the field of DNA sequencing of plant species have made
it possible to undertake proteomics studies, as this allowed the creation of increasingly
complete protein databases. Although there are still many limitations due, for example, to
the occurrence of post-translational modifications and the availability of genomic data for
a limited number of species, the combination of proteomics with the other omics sciences
is pivotal to a deeper understanding of biological processes, being valid for vascular plants
and early plants. Various studies conducted on moss P. patens have highlighted the impor-
tance of this species to study mechanisms such as biotic and abiotic stress, or adaptation,
critical for the environmental interaction of plants, and to characterize stress-related genes
also through reverse genetics approaches [174]. For example, due to the possibility to
cultivate P. patens, under standardized conditions, in bioreactors or bubble flasks [175], an
adequate amount of plant material was achieved, allowing to perform a proteomic investi-
gation that resulted in being strategic to highlight the importance of protein secretome as a
key player in cell signaling and cell-to-cell communication in responses to fungal pathogens
elicitors [176]; this study demonstrated how the secretome of the moss was dominated by
pathogen defense-related proteins when plants were grown in liquid culture and treated
with chitosan: a strong oxidative stress was found as correlated with secreted peroxidase
Prx34, a peroxidase involved in defense against moss pathogens [177,178]. Authors ex-
ploited a shotgun approach, chromatography associated with tandem mass spectrometry
(LC–MS/MS), using an Orbitrap spectrometer coupled with Proxeon EASY-nLC system,
for the identification of extracellular proteins, while precipitation was analyzed by two-
dimensional electrophoresis (2-DE). Of the secreted proteins identified 70% were found
to be homologous to those secreted and characterized in Tracheophytes, some of them
belonging to the functional categories correlated to defense against pathogens; interestingly,
moss treated with chitosan presented 72 unique proteins that were not found in the control
samples: among them, chitinases and thaumatin were recognized, as frequently observed
in higher plants exposed to pathogens or defense-related elicitors. It should be noted that
industrial applications have been reported for proteins present in the filtrates of these
cultures, in the production of recombinant protein-based antifungal formulations [175].
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Similar shotgun proteomic method was also applied in the above mentioned study
investigating the response of liverwort M. polymorpha to P. palmivora [41], using an EASY-nLC
1200 coupled to an Exactive Plus Q mass spectrometer and a MaxQuant software (version
1.5.7.4, http://www.maxquant.org/) [179] with unlabeled quantification (LFQ) and iBAQ
enabled for mass spectra processing. Protein identification was conducted using a combined
database of M. polymorpha transcriptome sequences (http://marchantia.info) [141].
4.3. Metabolomics
In the last 10 years, several studies have been carried out on natural extracts from
different bryophytes, aimed at the characterization of interesting metabolites: arrays of
low molecular weight molecules constituting the “metabolic phenotype” (metabolome) of
selected organisms have been screened defined. The separation of most of these compounds
can be conducted using reverse phase liquid chromatography on a C18 column, coupled
to a high resolution mass spectrometer (QTOF-MS) through an atmospheric pressure ion
source (ESI or APCI). This technology proved to be effective in obtaining information on
the structure through the fragmentation of the analyzed compounds, due to the presence
of a quadrupole segment and a collision cell before the flight tube. The bioinformatic
analysis of metabolomic data (both LC/MS and GC/MS) requires the aid of tools that allow
the extraction of chromatographic and spectral data in a file format such as xcms [180],
metAlign [181], MzMine [182] or GridMass [183]. Tools for integrated GC/MS analysis are
also available, that allow one to perform peak alignment, RI calculation and MS spectra
matching in databases such as TargetSearch, TagFinder or FiehnLib. Derivatization is
reported to be not necessary for the analysis of volatiles and, due to the nature of the
matrix, the detection limit can be very low [184].
As for the other non-model organisms, the greatest challenge is the identification of
compounds due to the lack of constitutive reference spectra, the large number of completely
unknown compounds. In fact, in the near past, only a few studies in the literature are
found that performed untargeted metabolomics analyses (LC/MS, GC/MS and NMR) with
bryophytes [185–189]. More recently, an integrative ecometabolomics approach, which
proposed to connect biochemistry with ecology using bioinformatic methods, applied
untargeted liquid chromatography coupled with ultra-performance liquid chromatog-
raphy coupled to electrospray ionization quadrupole time-of-flight mass spectrometry
(UPLC/ESI-QTOF-MS) to obtain metabolite profiles of methanolic extracts from nine
bryophyte species (namely Brachythecium rutabulum, Calliergonella cuspidata, Fissidens tax-
ifolius, Grimmia pulvinata, Hypnum cupressiforme, Marchantia polymorpha L., Plagiomnium
undulatum (Hedw.) T.J. Kop., Polytrichum strictum and Rhytidiadelphus squarrosus), in order
to unravel their metabolic variation across seasons, as both their growth and biochemistry
are strongly dependent on the season: as a result, typical secondary metabolites possess-
ing antimicrobial and antifungal properties, such as apigenins, lunularic acid, lunularin,
various marchantins and perrottetin E, were identified, but other compounds belonging
to the classes of methoxyphenols, neolignans, cinnamic acids, lactones and anthocyanins,
active against fungal pathogens, were annotated [45,190]. Metabolite profiling of Sphag-
num fallax performed using two types of mass spectrometry (MS) systems and 1H nuclear
magnetic resonance spectroscopy (1H NMR) revealed a total of 655 metabolites—329 of
which were novel metabolites. Authors compared Sphagnum’s metabolite signature to
the metabolite composition of different plant species with known antimicrobial effects
(i.e., medicinal plants), finding 17 putative antimicrobial substances: network analysis
identified 211 known compounds and 21 unknown compounds that were first neighbors
of these 17 antimicrobial compounds, suggesting there are potentially other compounds
in the Sphagnum metabolome with antimicrobial properties. Other compounds known
for their potential against fungi as phenolic compounds, benzoic, caffeic and coumaric
acids derivatives, have been detected in a study carried out by HPLC-TOF/MS on Cryphaea
heteromalla extracts [84].
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Among all metabolites in bryophytes, lipids are considered one of the most important
groups, as they play many vital roles in energy storage, membrane formation, cell signal-
ing, functioning and environmental adaption [191]; they include all non-hydrophilic com-
pounds but overall terpenoids, that due to their antimicrobial and anti-inflammatory poten-
tial are considered the reason of the ethnobotanical used in traditional medicine [24,192,193].
Lipidomics, the emerging field for the high-throughput analysis of lipid-related metabolic
pathways in animals and in plants, essentially relies on the screening of biomarkers by un-
targeted lipid analysis using liquid chromatography–mass spectrometry (LC–MS), which
allows for the separation and identification of possible lipophilic compounds and deriva-
tives. LC-based lipidomics is relatively rapid and usually requires less sample than GC-
derived methods, since only 2–10 mg of leaf dry weight is needed, but these advanced
techniques only recently have been applied on bryophytes extracts: in 2017, Gacet and
coauthors employed targeted metabolomics using LC–MS/MS and GC–MS to study signal-
ing lipids in 71 plant species, representative of major phylogenetic clades, to systematically
investigate the distribution of lipids in the plant kingdom; they found a fascinating positive
phylogenetic correlation in the jasmonic acid (JA) abundance of early plants versus An-
giosperms and Gymnosperms [194]. JA and its derivatives, jasmonates, belong to the class
of oxylipins, bioactive metabolites derived from the oxygenation of acidic polyunsaturated
fats [195]: besides primarily exerting regulatory functions involved in plant reproductive
development and vegetative growth, jasmonates not only play critical roles in the defense
response against wounds and attacks by pathogens, but also have been recently reported
to possess a direct antifungal activity against a number of fungal phytopathogens [196].
Gachet et al. demonstrated that, while completely absent in algae, JA started to be detected
in small to intermediate amounts in bryophytes (namely: hornworts Anthoceros agrestis,
Anthoceros punctatus and Phaeoceros laevis; mosses Physcomitrella patens, Funaria hygrometrica,
Polytrichum juniperinum, Hedwigia ciliata and Hylocomium splendens and liverworts Cono-
cephalum conicum, Marchantia polymorpha and Riccia fluitans), with the ending to be more
represented in higher plants. They therefore speculated that the phylogenetic distribution
of JA, and other lipids, could be a consequence of interactions/adaptations of plants to the
surrounding environment, including chemical interactions and defense mechanisms, not
completely elucidated yet.
5. Most Common Techniques for the Validation of Antifungal Activity of Bryophyte
Extracts/Compounds
From the 50s, a systematic literature about laboratory tests aimed to evaluate the bio-
logical properties of bryophyte extracts appeared, and, during the following five decades,
aqueous and alcoholic extracts and isolated compounds from about 150 species of liv-
erworts and mosses had been successfully tested against fungi and bacteria in in vitro
assays [9,100,197–207]. In a complete report of several bryophytes extracts/purified com-
pounds showing activity (or investigated) against human and plant pathogenic fungi
published in 2011, the different modes of action of such bryoactives were described: among
them, spore germination inhibition, development of anomalies in the hyphae, formation
of flaccid cell wall and granulated cytoplasm, inhibition of chitin production and the in-
duction of reactive oxygen species (ROS) associated with mitochondrial dysfunction were
noticed [208]. The mechanism of activity has been reported as not only dependent on the
compound, but also pathogen specific; in addition, same compound was reported to follow
a different mode of action while inhibiting the same or different fungi.
The majority of such investigations were essentially based on agar plates tests, but
it is a fact that when we review a more recent literature about the antifungal activity of
compounds or plant extracts, we face a plethora of studies difficult to compare, because of
the use of different non-standardized approaches, growth media, inoculum preparation
techniques and size, treatment conditions and time of determination; if the most known and
simple methods are the disk-diffusion and broth or agar dilution assays, basically aimed at
testing the antifungal properties of plant-derived agents, other procedures such as the time-
kill test and flow cytofluorometry have been described and applied to obtain more punctual
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information on the nature of the inhibitory effect (whether fungicidal or fungistatic, its
time- or concentration-dependence, etc.) and the specific cell damage inflicted to the target
microorganism. Owing to the fascination towards the properties of bryophyte bioactives,
and with an eye on the multidrug-resistance occurrence in both agricultural and human
relevant fungal species, it is important to develop a better understanding of the existing
methods available for characterizing and/or quantifying the biological effect of extract
or pure compounds for its applications in various fields. Therefore, in this review, we
provided a panel of the in vitro and in vivo techniques suitable for evaluating the activity
of natural compounds against fungi, along with some examples of employment.
5.1. In Vitro Methods
Spore germination assay: For the evaluation of bryophyte extracts on fungal spore
germination the slide technique has been reported [209,210]. Bryophyte extract of the
desired concentration is added as a film to the surface of dried slides or in the cavity of
the slide using the hanging drop method [211]. The suspension of fungal spores is taken
and spread over the film. In the controlled treatment, distilled water is added in place of
spore suspension. Slides are then incubated at 25 ± 2 ◦C for 24 h. After incubation, slides
are fixed in lactophenol cotton blue and observed microscopically for spore germination.
Percentage spore germination is calculated recording the number of germinated spores/the
total number of spores [212]. Hyphal length can also be measured with this assay after 8 h
from inoculation [213].
Poisoned food technique: in this test, especially used for antifungal testing, potato dex-
trose agar (PDA) medium is mixed with the desired concentration of sterilized bryophyte
extract and the mixture is poured into the sterilized Petri dishes [214]. The Petri dishes
supplemented with the same amount of distilled water instead of extract represent the con-
trol. After the complete solidification of the medium, mycelium plugs from five-to-seven
days-old fungal culture were inoculated aseptically on 5–7 mm diameter paper disc. The
fungal discs are then put in the center of the agar plate. The plates are then incubated at
25 ± 2 ◦C for 27 h [20] up to seven days. The colony diameter is measured in millime-
ters [215], while the toxicity of the extract is calculated in terms of the percentage of mycelial
growth inhibition comparing the colony diameter of the poisoned plate (with bryophyte
extract) and nonpoisoned plate (with distilled water) and calculated using the formula of
Pandey et al., 1982 [216] C−T / C × 100, where C = average diameter (mm) of the fungal
colony in the control plate and T = average diameter (mm) of fungal colony in treatment
plate.
Disc diffusion assay [217]: Petri dishes are filled with Sabouraud dextrose agar and are
seeded using a sterile cotton swab with 100 mL of fungal spore suspension diluted usually
until 1–2 × 105 spores/mL. A sterile filter disc of 6 mm diameter was placed into the plates
and impregnated with bryophyte extract (0.5–10 mg/mL). Flucanazole (1–10 mg/mL),
ketoconazole (50 µg/mL) or nystatin (10 µg/mL) are commonly used as a positive control
in place of the extract. The plates are then incubated at 25 ◦C for 24/48 h. After incubation,
the zones of growth inhibition around the discs are measured in millimeters [19].
Agar well diffusion assay: Petri dishes are filled with Sabouraud dextrose agar and
seeded using a sterile cotton swab with 100 µL of fungal spore suspension usually diluted
until 1–2 × 105 spores/mL. A well of 6 mm diameter is cut into the center of plates
and filled with up to 100 µL bryophyte extract (from 10 to 100 mg/mL). Fluconazole
(1–10 mg/mL), ketoconazole (50 µg/mL) or nystatin (10 µg/mL) are used as a positive
control. The plates are then incubated at 28 ◦C for 72 h. After incubation, the zone of
growth inhibition around the well is measured in millimeters [23,218].
Autobiochromatographic TLC screening or direct bioautography: the plant extract
diluted with the appropriate solvent is applied on the silica gel-coated plate. The plate
is developed with a different ratio of solvents, e.g., ether [219] or acetone [15] to sepa-
rate the phytochemicals. When dried, the plate is sprayed with a conidial suspension of
106 spores/mL [220] and incubated for 48 h at 25 ◦C under humid condition. The fungal
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growth is evaluated under UV light [219]. In alternative, plates could be sprayed with tetra-
zolium salts (e.g., MTT), reincubated at 25 ◦C for 24 h or at 37 ◦C for 3–4 h [15,221]: clear,
white zones against a purple background on the plate, due to the reduction of tetrazolium
salts to formazan by the dehydrogenases of living fungi, indicate the antimicrobial activity
of the bryophyte extract.
Microdilution method: the microdilution technique is performed in sterile 96-wells
plate using a final volume of 200 µL. Inoculum of fungal spores is used at a final concentra-
tion of 1.0 × 106 spores/mL in a volume of 100 µL per well. The bryophyte extracts are
added to the broth medium with fungal inoculum to achieve the desired concentrations
(0.05–20 mg/mL). The solvent used for preparing bryophyte extracts and a commercial
fungicide (usually bifonazole at concentrations 0.1, 0.5 and 1 mg/mL) are used as a control.
The plates are incubated for 72 h at 28 ◦C, and the minimum inhibitory concentration
(MICs) of plant extracts is determined qualitatively at the binocular microscope by observ-
ing the presence of fungal growth, or quantitatively by determining the absorbance of each
well at 620 nm with a microplate reader [222]. Moreover, several colorimetric methods
based on the use of tetrazolium salts are often used for the MIC endpoint determination, in
the antifungal microdilution method [223]. A variation of microdilution assay has been
applied for the evaluation of antifungal potential of two mosses against Aspergillus flavus
and Candida albicans [210].
Flow cytofluorometry: this technique is based on the use of a fluorescent dye, mainly
propidium iodide (PI) that is an intercalating agent, for the detection of cell membrane
damage. PI fluorescence intensity data are collected for 10,000 cells, using a single laser
emitting excitation light at 488 nm, and cell membrane damage is demonstrated by an
increase in PI staining. This parameter is displayed as the log of the mean PI fluorescence
intensity on the x axis of a histogram chart. The flow cytofluorometric method is capable
to discriminate three distinct subpopulations (dead, viable and injured cells), allowing
one to evaluate the antifungal activity of the plant extract on the tested microorganism.
Fungal spores suspension is mixed with an equal volume of plant extract and shook for the
desired time, usually 25 ◦C for 24 h [224] or 10 min at room temperature [225]. Then, the
cells are pelleted, resuspended in PI solution (25 µg/mL in phosphate-buffered saline) and
incubated in the dark for 30 min at 32 ◦C. This method has been demonstrated to rapidly
provide reproducible results, usually in 2–6 h.
5.2. In Vivo Methods
Mouse assay: to determine in vivo antifungal activity of bryophyte extracts, groups
of male mice were challenged with 105 fungal spores per mouse and later treated with
different doses of plant extract (25, 50 and 100 mg/kg) or ketoconazole (as antifungal
medication). One spore-challenged group, served as a control, received the solvent used
for the bryophyte extract. Mortality of mice was observed daily for 30 days [226].
Plant protection assay: this method was applied in the pathosystem Botrytis cinerea/green
pepper. Plants were sprayed with the bryophyte extracts (1% m/v in distilled water con-
taining 0.0125% Tween20 as a surfactant) or with a fungicide as the control; after 4 h, the
pathogen was inoculated by spraying a conidial suspension of 1 × 106 conidia/mL. Plants
are then incubated at 25 ◦C for 48 h. Disease severity was visually estimated as a percentage
of infected leaf area in relation to total healthy tissues of sampled leaves [227].
6. Conclusions
Humankind has always been interested in plants not only as a source of food, but
also as a tool for healing purposes; hence, since the herbal medicine represented the first
and foremost therapeutic tool available to humans for many centuries, the history of
plant-derived drugs—starting from Dioscoride’s De materia medica—is as old as the world.
Currently, great resources are invested by multinational companies on herbal drugs and
preparations. However, dragged by the timeless challenge between pathogens and their
hosts, the global effort for the individuation and production of effective formulations has
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to contend between the insurgence of microbial resistance phenomena and an increasing
necessity for environmental safety and sustainability.
Plants should be probably thought as the most formidable chemical laboratory that
can be exploited for the production of an incredible number of biologically active molecules,
and also bring the considerable advantage to perform as a renewable natural resource
for these bioactives. The remarkable structural and chemical diversity possessed by such
natural compounds cannot be matched by any synthetic libraries of small molecules, since
they are evolutionarily optimized as drug-like molecules and remain the best sources of
drugs and drug leads. In fact, this diversity is the result of the coevolution of each plant
species with an even greater number of pathogens, predators and competitors: thus, unlike
newly synthesized compounds, plant secondary metabolites are virtually guaranteed
to exert biological activity that is highly likely to function in protecting the producing
organism from, for example, a specific microbial pathogen.
The importance of botanical pesticides, and fungicide in particular, is attributed to
their efficacy, biodegradability, varied modes of action, low toxicity and availability of
source materials; however, to date, they are mostly obtained from higher and flowering-
plants, probably due to the availability of long-dated knowledge background, a wider
range of organ/tissue-based chemical diversity and a greater possibility of cultivation for
industrial purposes. Bryophytes, non-vascular plants that left the aquatic environment for
colonizing terrestrial lands around the Ordovician, evolved key adaptation mechanisms
to cope with both abiotic and biotic stresses, including microbial pathogens, and contain
many unique chemical compounds with high biological and ecological relevance. Hence,
despite being lesser considered pivotal producers for natural pesticides than higher plants,
their potential as a source of antifungal bioactives—to be exploited against both human
and plant pathogens—should be emphasized, and it is worthy of investigation.
We aimed at reporting, reviewing and highlighting the various metabolites produced
by bryophytes that have been found to exert antifungal bioactivity—or that, even if sus-
pected to possess a potential, it has to be confirmed still, the present work represents our
effort to contextualize them in their evolutionary, metabolic and investigational framework.
Omics technologies and approaches, and the panel of biological assays overviewed, played
(in the past, as they can definitely continue to play in the future) a unique role in individu-
ating and/or characterizing molecules with antifungal properties buried in the treasure
chest of these stunning, early-diverged land plants. In fact, beside already acknowledged
bryoactives, for those compounds for which antifungal properties were not demonstrated
yet, the hypothesis that, due to their biochemical derivation, a similar biological activity
could be suggested, deserves further investigations.
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